Now, epilepsy drug fails quality test

L-G VK Saxena has recently ordered CBI probe after samples of 5 drugs failed quality tests

- ASHISH SRIVASTAVA

DAYS after samples of multiple drugs available at major government hospitals and Aam Aadmi Mohalla clinics failed the quality test, prompting L-G VK Saxena to recommend a CBI investigation in the matter, samples of a medicine used for treating of epilepsy has been found to be spurious.

Sodium Valproate, an antiepileptic medication that controls seizures or fits, has reportedly "not met the standard quality" in an examination done at Regional Drug Testing Laboratory, Chandigarh (RDTL).

One-third of the samples sent for testing failed the quality examination, the report revealed.

"In dissolution test, out of 24 units seven units were found less than Q-15 and one unit was found less than Q-25, as per IP 2022 the limit of Q is NLT 75%," the report said.